Table 2.

Cumulative brute mortality in each cohort

Mortality	2010–12 n = 591	2018–20 n = 642	p value
In-hospital, overall	14/591 (2.5%)	13/642 (2.0%)	0.339
Female	8/445 (1.8%)	7/450 (1.5%)	0.491
Male	6/146 (4.1%)	6/192 (3.1%)	0.421
Age 65–79	4/420 (0.9%)	4/424 (0.9%)	0.632
Age ≥ 80	10/171 (5.8%)	9/218 (4.1%)	0.291
ASA I–II	2/402 (0.5%)	0/401 (0%)	0.497
ASA III–IV	12/189 (6.3%)	13/241 (5.4%)	0.413
Charlson ≤ 2	2/254 (0.8%)	1/244 (0.4%)	0.515
Charlson > 2	12/578 (2.1%)	12/398 (3.0%)	0.234
At 30 days, overall	49/591 (8.3%)	35/642 (5.5%)	0.031*
Female	39/445 (8.8%)	25/450 (5.5%)	0.040*
Male	10/146 (6.8%)	10/192 (5.2%)	0.341
Age 65–79	18/420 (4.3%)	8/424 (1.9%)	0.033*
Age ≥ 80	33/171 (19.2%)	27/218 (12.3%)	0.042*
ASA I–II	3/402 (0.7%)	2/401 (0.5%)	0.501
ASA III–IV	46/189 (24.3%)	33/241 (13.7%)	0.003*
Charlson ≤ 2	2/254 (0.8%)	1/244 (0.4%)	0.673
Charlson > 2	47/578 (8.1%)	34/398 (8.5%)	0.453
At 1 year, overall	95/591 (16.1%)	77/642 (11.9%)	0.023*
Female	71/445 (16.2%)	47/450 (10.4%)	0.009*
Male	23/146 (15.7%)	30/192 (15.6%)	0.545
Age 65–79	60/420 (14.3%)	47/450 (10.4%)	0.052
Age ≥ 80	35/171 (20.4%)	30/218 (13.7%)	0.053
ASA I–II	36/402 (8.9%)	28/401 (6.9%)	0.183
ASA III–IV	59/189 (31.2%)	49/241 (20.3%)	0.006*
Charlson ≤ 2	33/254 (12.9%)	32/244 (13.1%)	0.536
Charlson > 2	62/578 (10.7%)	45/398 (11.3%)	0.426

Data as n (%)

*Significant p value